If asked to choose between a brain that looked nice, or one that functioned well, most of us would choose the second. Furthermore, the ultimate importance of cerebral disease is that it affects brain function, not appearance. Yet timing restraints of PET. On the other hand, because they emit single y rays (hence single photon ECT), coincidence detection cannot be used to yield spatial information, which must, therefore, depend on collimation alone. Furthermore, signal attenuation by surrounding tissues cannot be corrected by an exact solution with transmission scan data as used in PET. Partly for the foregoing reasons, SPECT has a lower spatial resolution than PET. Nevertheless, because of the lower cost of SPECT and the greater availability of machines, SPECT has found an altogether larger place in the clinical arena than PET. Measurements by SPECT take minutes to hours. As with PET, radiation considerations preclude frequent repeat measurements. In magnetic resonance methods,4 the divide between structural and functional imaging is precarious. For example, is magnetic resonance angiography (MRA) a functional or an anatomical measurement-because it shows the anatomy of the major cerebral vessels using a sequence that is specifically sensitive to the movement of the contained blood? In this review I use the term functional magnetic resonance imaging (fMRI) to refer to a range of MR sequences designed to acquire information about brain function. These techniques are newer than either PET or SPECT and the scientific literature concerned with their use has so far been more methodological than medical. Nevertheless, at least two fMRI approaches deserve mention-namely, echoplanar imaging (EPI), and fast low angle shot (FLASH) techniques. Each is concerned with the generation of images where a change in signal with time is most likely the consequence of changing neuronal function, the mediator between the two being a change in small vessel flow, or at least an increase in localised venous return. The present possibilities and imminent potentials of fMRI have been described in several recent reviews. [5] [6] [7] Whereas the basics of PET and SPECT methodology follow parallel processes in other techniques such as photography and x ray computerised tomography, MRI has no easy parallel in our other experiences. The fundamentals of magnetic resonance have been covered by Moseley in this Journal (1995;58:7-21) ; see also Luflkin4). Conventional MR sequences build up an image in steps, using a series of magnetic field gradients to specify anatomical positions within the tissue of interest. In EPI an image is recovered from the signal generated by a single free induction decay over a fraction of a second.8 On the other hand, FLASH sequences limit the time taken for scanning by minimising the perturbation of the magnetisation from its equilibrium so that successive excitation pulses can follow each other more quickly. Reported data from EPI at high (3 Tesla) field strength include images acquired in 0-1 s with a spatial resolution of 075 mm. 9 Despite the large number of MRI machines available for diagnostic purposes, few have either EPI or high (2-3 Tesla) field strength. It is possible to acquire FILASH fMRI images at a lower field strength (1-5 Tesla) with a "clinical" MR imaging system; although signal acquisition is in this case somewhat slower.'0 All fMRI methods share one advantage over PET and SPECTnamely, the avoidance of ionising radiation.
Practicalities of the techniques Because functional imaging studies have yet to enjoy wide use as clinical tools in routine neurological practice, the following account describes elements of the basic principles, as well as the nuts and bolts practicalities of patient scanning. PET 
General principles
The general principle of the PET measurement requires a mathematical model that corresponds to the functional system under scrutiny. This model is an approximation of the processes that lie between the "input" (the activity given to the patient and available to the brain via its arterial supply or by inhalation) and the "output" (the activity measured regionally during the course of the experiment).
Cerebral bloodflow
One of the simplest PET models relates to the measurement of regional cerebral blood flow during continuous inhalation of C'50,.
After a few minutes inhalation, an equilibrium is reached whereby the arterial supply of radioactivity to the brain is equal to the loss of activity from venous washout and radioactive decay (the so called steady state condition). In this situation a simple mathematical expression describes the regional cerebral blood flow in terms of known or measurable values-namely, the radioactive decay constant (fixed for 150), the arterial activity of H,150 (in pCi/ml, measured in an arterial blood sample with a well counter), and the regional brain concentration of tracer in units/ml (measured in the PET camera). The steady state measurement of regional cerebral blood flow takes about 15 minutes to complete.
On the practical side, these measurements (and all of those listed below) require that the patient be still during image acquisition. They require a venous line for tracer administration (except when C'50", C'50, or 1502 are given by inhalation). Most quantitative studies also require an arterial line to measure the level of radioactivity presented to the brain over the time course of the scan.
Blood flow can also be measured during the rise and fall of brain radioactivity surrounding a bolus inhalation or injection of tracer. The mathematical model required to unscramble the collected data to a measured value for rCBF is in this case very much more complicated," but the method is faster (data acquisition takes only two to three minutes). Sawle Oxygen metabolism Oxygen metabolism can be calculated from cerebral blood flow after additional measurements of the oxygen extraction fraction (the percentage of the available blood oxygen extracted during its passage through the brain vasculature; usually measured after inhalation of 1502) and regional blood volume (a correction for the percentage of any cerebral region that contains blood rather than brain). ' SPECT 
General principles
The practicalities of SPECT measurements are for the most part simpler than for PET. In part this is because SPECT data are by necessity less quantitative than PET data. Another relevant factor may be the closer liaison and relation between SPECT and clinical medicine, with the restraining hand of clinical practicality curbing the imager's urge to add complexity in the pursuit of accuracy.
Cerebral bloodflow
The SPECT approach to cerebral blood flow hinges on the finding that certain tracers are irreversibly taken up into the brain in a regional pattern that reflects localised differences in cerebral blood flow. After intravenous injection, [ Patients undergoing SPECT measurement of cerebral blood flow with these techniques do not need to be in the camera during tracer injection. They should, however, be rested at this time because it is blood flow around the time of injection that is measured during the later scan, not blood flow at the time of the measurement, as in PET.
For the most part, the interpretation of SPECT flow images follows the radiological tradition-namely, interpretation of the image appearance by an expert in the field.
As with the assessment of age related atrophy on structural images, the observer must take into account the known changes in cerebral blood flow that accompany the normal ageing process. Such images are often reported alongside structural images to help in the differentiation between normal and pathological appearances. General principles Procedures for fMRI are very different from either PET or SPECT, being independent of ionising radiation. Aside from any activity that the patient might be asked to perform while in the magnet, the patient's experience of fMRI is unlikely to differ greatly from any other MR procedure (loud noises in a dark tunnel), although EPI imaging is presently particularly noisy. Although rapid MR sequences (such as EPI) yield clear images of moving structures (such as a beating heart or a waving head) fMRI methods rely on a comparison of successive scans of the same area. In this case, the head position must be identical for the acquisition of each of the images contributing to data analysis. Even the tiniest head movements can wreck havoc with fMRI analysis; indeed it has even been possible to create striking "functional" data as a result of head movement artefact alone.'2 As with PET, one approach to the problem of head movement between scans may be to realign the data in software after image acquisition.3 '4 What has been learned with these techniques, and to what extent may they be used in clinical practice? Both PET and SPECT have been used in neuroscience research to examine brain function in health and in disease. Thus far fMRI has been most closely applied to the study of healthy subjects, although this will certainly change. This Early PET studies measured regional cerebral blood flow, blood volume, oxygen extraction, and oxygen metabolism to examine the pathophysiology of stroke, particularly the mechanisms of cerebrovascular compensation in the face of falling and failing arterial perfusion pressure.3536 Currently PET and SPECT can both detect cerebral ischaemia in acute stroke at a stage when CT images are still normal. It has been shown that PET also has some ability to predict the extent of functional recovery from stroke37 and in recovered patients (using functional mapping) it can show the anatomical and functional substrate of recovered function. 38 39 Likewise PET and SPECT can show evidence of hypoperfusion ("misery perfusion") in the absence of infarction,40 and hyperperfusion ("luxury perfusion") at a site of previous infarction. Haemodynamic changes can be shown by PET in patients after extracranial-intracranial bypass operations.4' Although this operation has not been shown to be of benefit in large interventional studies42 it is possible that preoperative functional imaging could be used to identify patients more likely to gain from operation.
Basic 75 but not all,76 have shown no effect of age on ['8F]dopa uptake), the detection of presymptomatic disease (fig 2) , the rate of progression of clinically evident disease,78-80 and the efficacy of neurotransplantation procedures (fig 3) .8182
Various other akinetic rigid conditions have been studied by [ Parkinson's disease, and two members of a sibship with familial parkinsonism. The symptomatic patient shows profoundly impairedfluorodopa uptake whereas the presymptomatic subject (who became clinically affected within months of the scan) shows fluorodopa uptake at a level internediate between normal and parkinsonian values. In part, the answer to the problem of differential diagnosis by PET in individual patients might be helped by multiple tracer studies to examine receptor status as well as (or in place of) ['8F]dopa uptake. There are many publications concerning dopamine D2 receptors in akinetic-rigid syndromes. On balance PET and SPECT studies suggest relative upregulation of D2 receptors in patients with early Parkinson's disease, with normal or even lower levels later in disease; perhaps in part as an effect of treatment with dopaminergic drugs (PET148798 101; SPECT'02>'04). Patients with multiple system atrophy are more likely to have low D2 ligand binding (PET'4 84) and low tracer uptake in dopa naive akinetic-rigid patients may predict subsequent evolution to multiple system atrophy rather than Parkinson's disease (PET'4; SPECT'05) (fig 4) . Unlike the D2 system, PET studies of dopamine Dl receptors have shown no evidence of up regulation in early levodopa naive patients.'3 Other neurotransmitter receptors have also been studied in akinetic-rigid syndromes. Specifically, striatal ["lC]diprenorphine binding has been shown to be impaired in patients with multiple system atrophy, but not in patients with Parkinson's disease. 106 In a study using Figure 4 levodopa treatment, whereas early treatment with levodopa would be appropriate in a patient in whom [18F]dopa PET showed uptake close to or in the lower normal range.
Patients undergoing experimental neurotransplantation procedures may also gain some direct personal benefit (graft site selection, for example)81 but otherwise for now, the principal promise of functional imaging in movement disorders is in the advancement of our understanding of disease, causation, and treatment. 6) .121123 In some cases it has been possible to scan patients during seizures, in which case areas that are interictally hypometabolic may become ictally hypermetabolic or show high flow.122 124 125 It has been reasonably argued that such regions represent epileptic foci, even in the absence of corroborative findings from structural imaging or EEG. In patients with intractable epilepsy, surgical excision of a definite seizure focus may radically improve clinical status. Current MRI techniques are able to identify structural abnormalities in an increasing number of such patients. There are, nevertheless, a significant number of patients in whom noninvasive means fail to clearly identify a seizure focus. Options in these patients include the placement of depth electrodes and functional imaging studies.
In found with CT or MRI.128 As in many other areas of imaging the ground is shifting rapidly. With increasing structural resolution in MRI (including hippocampal volume measurements) the balance is swinging in favour of MRI having a greater chance of correct lateralisation than SPECT. 69 A recent fMRI study of a four year old boy showed changes in image signal restricted to an area of structural abnormality during five seizures over a 25 minute period. Interictal SPECT showed reduced [99mTc]HMPAO uptake in the same region, whereas increased uptake was found during a seizure.129 CLINICAL 
INDICATIONS
Both interictal and ictal functional imaging studies may show areas of abnormal signal in patients with focal epilepsy. This localisation is appropriately used to confirm or refute collateral evidence from structural MRI and EEG examinations in the assessment of patients with refractory epilepsy who are being considered for surgical treatment (usually a partial temporal lobectomy). also been made of SPECT in an effort to differentiate high from low grade gliomas. Thallium-201 (a tracer more familiarly used in myocardial studies) exhibits increased uptake in some tumours. In gliomas, uptake is greater in high grade lesions.I"'
A particular clinical problem in neurooncology is the management of patients presenting with recurrent lesions after radiotherapy for tumour. It can be difficult to differentiate recurrent tumour from radiation induced necrosis on the basis of clinical assessment and structural imaging alone.
['8F]Fluorodeoxyglucose PET is of clinical use in this situation,"34 as recurrent tumour has a high metabolic rate (fig 7) , whereas low ['8F]fluorodeoxyglucose uptake suggests radionecrosis."35 The measurement is not affected in the early postoperative period, nor by steroid treatment." 35 Other aspects of tumour biochemistry have also been explored with PET, including measurements of amino acid uptake and protein synthesis. ["C]Methionine accumulates readily in gliomas,"36 higher uptake usually occurring in high grade tumours.'37 DNA synthesis can also be followed with nucleosides such as deoxyuridine labelled with fluorine-18."38 Peripheral benzodiazepine (w3) receptors are expressed on human glioma cells; the presence of this tumour marker may be recognised with PET and the specific marker The principal consensus use of functional imaging in oncology is in the differentiation of recurrent cerebral glioma from postradiation necrosis.
Summary of clinical indications for functional imaging studies As mentioned at the outset of this review, the cornerstone of clinical neuroimaging procedures has been the identification of broadly "structural" changes in neural tissue. The tools for such image acquisition (x ray CT and MRI) are widely available and of increasingly high quality and resolution. 
